{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:21:36Z","timestamp":1792146096186,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/mph.0b013e3182011676","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T04:26:01Z","timestamp":1304655961000},"page":"e195-e197","source":"Crossref","is-referenced-by-count":14,"title":["High Aromatase Activity and Overexpression of Epidermal Growth Factor Receptor in Fibrolamellar Hepatocellular Carcinoma in a Child"],"prefix":"10.1097","volume":"33","author":[{"given":"Katsumi","family":"Muramori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syouhei","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiriko","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PAP.0b013e3180504913","article-title":"Review of the clinicopathologic features of fibrolamellar carcinoma.","volume":"14","author":"Torbenson","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"R2-25-20210227","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.21703","article-title":"Outcome of patients with fibrolamellar hepatocellular carcinoma.","volume":"106","author":"Stipa","year":"2006","journal-title":"Cancer"},{"key":"R3-25-20210227","first-page":"903","article-title":"Hepatocellular carcinoma in the youth. A comparative analysis with hepatocellular carcinoma in adulthood.","volume":"52","author":"Hernandez-Castillo","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"R4-25-20210227","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.11292","article-title":"Fibrolamellar hepatocellular carcinoma in children and adolescents.","volume":"97","author":"Katzenstein","year":"2003","journal-title":"Cancer"},{"key":"R5-25-20210227","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hep.510260412","article-title":"Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.","volume":"26","author":"Pinna","year":"1997","journal-title":"Hepatology"},{"key":"R6-25-20210227","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/modpathol.3800449","article-title":"Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.","volume":"18","author":"Kakar","year":"2005","journal-title":"Mod Pathol"},{"key":"R7-25-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/pmj.78.924.584","article-title":"Epidermal growth factor receptor and bladder cancer.","volume":"78","author":"Colquhoun","year":"2002","journal-title":"Postgrad Med J"},{"key":"R8-25-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1309\/WF10QAAED3PP93BH","article-title":"Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma.","volume":"129","author":"Buckley","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R10-25-20210227","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<136::AID-MPO8>3.0.CO;2-L","article-title":"A childhood fibrolamellar hepatocellular carcinoma with increased aromatase activity and a near triploid karyotype.","volume":"28","author":"Hany","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R11-25-20210227","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1542\/peds.82.3.379","article-title":"Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver.","volume":"82","author":"McCloskey","year":"1988","journal-title":"Pediatrics"},{"key":"R13-25-20210227","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/rg.282075153","article-title":"Best cases from the AFIP: fibrolamellar hepatocellular carcinoma.","volume":"28","author":"Smith","year":"2008","journal-title":"Radiographics"},{"key":"R14-25-20210227","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/000992289803700606","article-title":"Evaluation of boys with marked breast development at puberty.","volume":"37","author":"Sher","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"issue":"suppl 4","key":"R15-25-20210227","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis.","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"key":"R16-25-20210227","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/annonc\/mdi006","article-title":"Impact of EGFR expression on colorectal cancer patient prognosis and survival.","volume":"16","author":"Spano","year":"2005","journal-title":"Ann Oncol"},{"key":"R17-25-20210227","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.humpath.2005.12.009","article-title":"Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.","volume":"37","author":"Buckley","year":"2006","journal-title":"Hum Pathol"},{"key":"R18-25-20210227","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nbt0404-363","article-title":"Erbitux diagnostic latest adjunct to cancer therapy.","volume":"22","author":"Mitchell","year":"2004","journal-title":"Nat Biotechnol"},{"key":"R19-25-20210227","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer.","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"key":"R20-25-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1749-6632.2009.03706.x","article-title":"Aromatase in nontumoral and malignant human liver tissues and cells.","volume":"1155","author":"Carruba","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R21-25-20210227","first-page":"4693","article-title":"Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer.","volume":"25","author":"Kawai","year":"2005","journal-title":"Anticancer Res"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3182011676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:27:23Z","timestamp":1786044443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201107000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182011676","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}